within Pharmacolibrary.Drugs.ATC.J;

model J01EC02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 1.1 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,
    adminCount     = 1,
    Vd             = 0.00045,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.010666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Sulfadiazine is a sulfonamide antibacterial agent used primarily in combination with pyrimethamine to treat toxoplasmosis. It has also been used in urinary tract infections and meningitis. Sulfadiazine acts by inhibiting bacterial folic acid synthesis. It is still used, but its use has declined due to resistance and availability of better tolerated agents.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after a single oral dose.</p><h4>References</h4><ol><li><p>Tajima, T, et al., &amp; Shimoda, M (2023). Oral pharmacokinetics of sulfadiazine and sulfamonomethoxine in female Holstein milking cows. <i>The Journal of veterinary medical science</i> 85(7) 715–720. DOI:<a href=&quot;https://doi.org/10.1292/jvms.23-0110&quot;>10.1292/jvms.23-0110</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37225451/&quot;>https://pubmed.ncbi.nlm.nih.gov/37225451</a></p></li><li><p>Xu, N, et al., &amp; Ai, X (2021). Sulfadiazine pharmacokinetics in grass carp (Ctenopharyngodon idellus) receiving oral and intravenous administrations. <i>Journal of veterinary pharmacology and therapeutics</i> 44(1) 86–92. DOI:<a href=&quot;https://doi.org/10.1111/jvp.12918&quot;>10.1111/jvp.12918</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33051869/&quot;>https://pubmed.ncbi.nlm.nih.gov/33051869</a></p></li><li><p>Xu, N, et al., &amp; Ai, X (2022). Comparative Pharmacokinetics of Sulfadiazine and Its Metabolite N4-Acetyl Sulfadiazine in Grass Carp (. <i>Pharmaceutics</i> 14(4) –. DOI:<a href=&quot;https://doi.org/10.3390/pharmaceutics14040712&quot;>10.3390/pharmaceutics14040712</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35456543/&quot;>https://pubmed.ncbi.nlm.nih.gov/35456543</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01EC02;
